RN7SL393P

Across TCGA pan-cancer cohorts, RN7SL393P RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated RN7SL393P data layer.

The strongest signal is observed in mesothelioma (MESO), where higher RN7SL393P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL393P expression acts as an unfavorable survival marker, although some lineages such as OV and KIRC show a favorable association.

MESO, HNSC, and BLCA are the cancer types where RN7SL393P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	III,IV	0.151	0.588	<.001	72	view →
HNSC	OS	Tertile	IV	0.243	0.540	.008	33	view →
BLCA	DFS	Tertile	All	0.159	0.374	.012	30	view →
READ	DFS	Tertile	All	0.143	0.552	.011	30	view →
SKCM	DFS	Tertile	All	0.273	0.644	.002	24	view →
ACC	OS	Tertile	All	0.147	0.685	.018	18	view →
LIHC	DFS	Tertile	All	0.261	0.573	<.001	18	view →
OV	OS	Tertile	III,IV	0.866	0.824	.031	16	view →
ESCA	OS	Median	All	0.584	0.740	.023	8	view →
KIRC	OS	Quartile	All	0.924	0.846	.024	6	view →
LUSC	OS	Median	III,IV	0.582	0.740	.032	6	view →
KIRP	OS	Median	All	0.961	0.903	.025	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

RN7SL393P–MESO (OS)

Open the MESO breakdown →